Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Arzneimittel-Forschung|February 1, 1977
[Anti-ulcer agent pirenzepine (LS 519)--a tricyclic compound with particular physico-chemical properties (author's transl)]W Eberlein, G Schmidt, A Reuter, et al.British Journal of Pharmacology|November 7, 1998
Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodentsH A Wieland, W Engel, W Eberlein, et al.European Journal of Pharmacology|September 16, 2000
Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptorD Wu, W Eberlein, K Rudolf, et al.British Journal of Pharmacology|March 11, 2000
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonistH Doods, G Hallermayer, D Wu, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226H N Doods, W Wienen, M Entzeroth, et al.European Journal of Pharmacology|September 21, 1993
Characterization of BIBN 99: a lipophilic and selective muscarinic M2 receptor antagonistH Doods, M Entzeroth, H Ziegler, et al.Journal of Medicinal Chemistry|May 1, 1990
Specific bradycardic agents. 1. Chemistry, pharmacology, and structure-activity relationships of substituted benzazepinones, a-new class of compounds exerting antiischemic propertiesM Reiffen, W Eberlein, P Müller, et al.Regulatory Peptides|August 27, 1996
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological propertiesH N Doods, H A Wieland, W Engel, et al.European Journal of Pharmacology|December 28, 1999
BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonistH Doods, W Gaida, H A Wieland, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226H A Wieland, K D Willim, M Entzeroth, et al.Pageof 2